No profile data available.
Anteris Technologies Global Corp. (AVR) is a healthcare company in the heart treatment equipment industry, based in Toowong, Australia, with about 136 full-time employees.
In Q2 2026 (the quarter ended June 30, 2026) revenue was $1.01 million. UNITED STATES was its largest region in fiscal year 2025, with 84% of revenue. Its market capitalization was $187.04 million as of December 4, 2025.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of December 4, 2025.
, a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve.
UNITED STATES: 84% of revenue by region in fiscal year 2025, followed by GERMANY (14%).
$187.04 million as of December 4, 2025.
Listed companies of a similar size in the same industry (heart treatment equipment) include Kestra Medical Technologies, Ltd. (KMTS), Orchestra BioMed Holdings, Inc. (OBIO), Picard Medical, Inc. (PMI), Stereotaxis, Inc. (STXS).